OTLC, Oncotelic, AI Powered Immunology

Posted on February 5, 2022 by Daily Deals

Oncotelic Therapeutics, OTLC, is a unique Immuno-Oncology company at the cutting edge of medical research and discovery of precision medicine – Oncotelic is creating new pathways by combining AI tools to accelerate discovery by a magnitude, the AI (in the cloud) helps their team of scientists select the best and most effective molecules, eliminate subpar molecules from the earliest stage of discovery, thereby, saving precious time and increasing the chances of breakthrough discoveries, eliminating the probability of errors and omission by a significant margin, and by merging the AI tools with proven expertise in medicine, the Oncotelic team has cut the time and reduced R&D budget leakage and waste by a huge margin, at Oncotelic every R&D dollar is optimized to deliver better ROI and highly effective drugs/therapies in the most efficient manner than ever before.

Oncotelic is led by one of the most renowned scientists in America, a pioneer in immuno-oncology, a man with 39 Patents to his name and over 100 Patent Applications Pending – Dr. Vuong Trieu.

Dr. Vuong was a joint patent holder who helped develop the block-buster billion dollar drug Abraxane^™– now owned by Bristol-Myers Squibb, NYSE: BMY, a $144 billion dollar company.

Dr. Vuong has put together a team of highly distinguished scientists and researchers, and a superb management team with years of proven marketing, brand building and scaling experience – a team that has turned startups into multi-billion dollar enterprises.

Oncotelic Developing Distinct Drugs Targeting Several Extremely Brutal Diseases (Each of them has the potential to be a block buster) let’s focus on one for now.

Primary Focus:

The one we are most excited about for the time being (without diminishing the importance of the other drugs that are in various stages of development) is a potential therapy that could increase the efficacy of an existing FDA approved drug (by as much as 100%) a drug that has generated over $17 billion in revenue last year alone and expected to hit $20 billion in 2025. The name of the drug is Keytruda owned by Merck.

Keytruda meet > OT-101

What Dr. Vuong and his excellent team did here is absolutely breathtaking! Dr. Vuong likes Keytruda, it’s great and it’s helping a lot of folks but it could do more, a whole lot more! When you combine the existing drug (Keytruda) with Dr. Vuong’s breakthrough discovery (after the FDA approval) the initial indications are that the rate of efficacy of Keytruda can increase by up to 100%!

Dr. Vuong’s newly discovered – inhibitor blocker eliminator – when given to patients along with Keytruda, the patients who are currently not benefiting can benefit! Imagine the relief combo-therapy can bring to the patients and their families around the world, right now, a lot of patients who can not benefit from Keytruda alone – can soon benefit from the combination therapy which Dr. Vuong has discovered!

Dr. Voung’s discovery is one of the most brilliant things I’ve ever seen – let me recap – A highly successful FDA approved Block Buster Drug that’s on the market today, whose efficacy can jump as much as 100% from where it is now – That’s what motivates me and the team at Oncotelic, a lot of patients and their families are needlessly suffering now!

As an investor you obviously look at the size of addressable market and that’s what motivates investors, right? As I’ve mentioned Keytruda has made $17 billion for Merck last year – if Dr. Vuong’s invention/discovery helps increase the efficacy rate of Keytruda even by only 50%, you do the math! We are talking about an opportunity worth billions! Think about it.

OT-101 Pipeline

Oncotelic is an artificial intelligence driven immuno-oncology company with a robust pipeline of first in class TGF-β immunotherapies for late stage cancers such as gliomas, pancreatic cancer and melanoma. OT-101, the lead immuno-oncology drug candidate of Oncotelic, is a first-in-class anti-TGF-β RNA therapeutic that exhibited single agent activity in relapsed/refractory cancer patients.

Rare Pediatric Cancer Designation

Oncotelic is seeking to leverage its deep expertise in oncology drug development to improve treatment outcomes and survival of cancer patients with a special emphasis on rare pediatric cancers. Oncotelic also has rare pediatric designation for DIPG (OT-101), melanoma (CA4P), and AML (OXi 4503). The Company also acquired (“PointR”) Data in November 2019.

Management Team

Dr. Voung Trieu, PHD, CEO, Chairman

Dr. Trieu, an expert in pharmaceutical development, currently serves as CEO/Chairman of Oncotelic Inc. Previously he was President and CEO of Igdrasol- developer of 2nd generation Abraxane- where he pioneer the regulatory pathway for approval of paclitaxel nanomedicine through a single bioequivalence trial against Abraxane. When Igdrasol merged with Sorrento Therapeutics, he became CSO and Board Director. He was Board Director of Cenomed- a company focusing on CNS drug development. Before that he was Director of Pharmacology, Pharmacokinetics, and Biology at Abraxis where he lead the development of albumin encapsulated therapeutics along building high throughput platform for small molecules, mirRNA, kinases. Prior to that he was Group Leader at Applied Molecular Evoluton where he was developing biobetter for Humira and Enbrel. Before that he was Director of Cardiovascular Biology at Parker Hughes Institute. Dr. Trieu holds a PhD in Microbiology, BS in Microbiology and Botany. He is member of ENDO, ASCO, AACR, and many other professional organization. Dr. Trieu published widely in oncology, cardiovascular, and drug development. Dr. Trieu has over 100 patent applications and 39 issued US patents.

Seymour Fein, MD, CMO

Dr. Fein’s professional activities have been focused on drug development research for over 35 years. He has been extensively involved in the successful evelopment of numerous drugs, biologics and medical devices over this time leading to FDA approvals for over 20 drugs (NDAs, sNDAs, BLAs) and devices (PMAs). Dr. Fein began his career at Hoffmann-La Roche Ltd. as a senior research physician and was responsible for a clinical development program that led to U.S. Food and Drug Administration (FDA) approval of recombinant interferon-alpha for cancer treatment. Dr. Fein was also the medical director of Bayer Healthcare Pharmaceuticals (U.S.) where he was responsible for therapeutic areas including gastroenterology, oncology, and cardiology. He later served as medical director for Rorer Group (now part of Sanofi) and Ohmeda (now part of Baxter). Dr. Fein founded and has been managing partner of a clinical and regulatory consulting organization and has worked closely with the Division of Gastroenterology and Inborn Errors Products at the FDA. He has participated in the development of and FDA approval of numerous drug products in many therapeutic areas. Dr. Fein has successfully overseen entrepreneurial drug development leading to the FDA approval of two orphan drug products in the field of gastroenterology.

Dr. Fein received his B.A. degree from the University of Pennsylvania and his M.D. degree with honors from New York Medical College. He completed a three-year residency in internal medicine at Dartmouth and a three-year fellowship in medical oncology and hematology at Harvard Medical School, where he served as an instructor of medicine during his final fellowship year. Dr. Fein is board-certified in both oncology and internal medicine.

Amit Shah, CFO

Amit Shah, age 53, has served as a senior financial officer for a number of life science companies, including Chief Financial Officer at Marina Biotech, Inc., a publicly traded biotechnology company (2017 to 2018); Vice President of Finance & Accounting and Acting Chief Financial Officer at Insightra Medical Inc. (2014 to 2015); VP Finance and Acting Chief Financial Officer at IgDraSol Inc. (2013); Corporate Controller & Director of Finance at ISTA Pharmaceuticals (2010 to 2012); Corporate Controller at Spectrum Pharmaceuticals (2007 to 2010): and as Controller / Senior Manager Internal Audits at Caraco Pharmaceuticals Laboratories (2000 to 2007). In addition to his work with life sciences companies, Mr. Shah served as the Chief Financial Officer at Eagle Business Performance Services, a management consulting and business advisory firm (2018 through March 2019) and as a consultant and ultimately Senior Director of Finance – ERP, at Young’s Market Company (2015 to 2017). Mr. Shah received a Bachelor’s of Commerce degree from the University of Mumbai, and is an Associate Chartered Accountant from The Institute of Chartered Accountants of India. Mr. Shah is also an inactive CPA from Colorado, USA

Saran Saund, CBO/GM of AI Division

Silicon Valley entrepreneur, Saran has been founder, CEO and GM at startups and public companies. Passionate about applying technology innovations to real world markets, he successfully founded an AI consortium to accelerate enterprise adoption of AI which engaged leading universities and technology vendors. A startup veteran, his track record includes senior leadership roles at companies that were acquired by leaders such as Marvell (MRVL) and Qualcomm (QCOM). His startup Cybercash (CYCH) had a successful IPO on NASDAQ. Saran started his career at Xerox PARC pushing 1’s and 0’s as a software engineer

Anthony E. Maida III, PhD, Chief Clinical Officer-Translational Medicine

Dr. Maida, an expert in immuno-oncology, currently serves as Senior Vice President – Clinical Research at Northwest Biotherapeutics, Inc. Prior to joining Northwest Dr. Maida served as Vice President, Clinical Research and General Manager, Oncology, World-wide at PharmaNet, Inc. Prior to joining PharmaNet Dr. Maida served as Chairman, Founder and Director of BioConsul Drug Development Corporation and Principal of Anthony Maida Consulting International, servicing pharmaceutical firms, venture capital, hedge funds and Wall Street. Dr. Maida’s skill set includes the leading execution and oversight of finance, operations, research, clinical and scientific development, regulatory and manufacturing for the development of various oncology immunotherapies. Over the past 25 years Dr. Maida has served in a number of executive roles, including, Chairman, CEO, COO, CSO, CFO and business development. Over recent years Dr. Maida has raised, or assisted in financings, nearly $200 million for emerging biotechnology companies. Dr. Maida serves as an advisor, consultant and technical analyst for CMX Capital, LLC, Sagamore Bioventures, Roaring Fork Capital, Toucan Capital, North Sound Capital, The Bonnie J. Addario Lung Cancer Foundation and vFinance; the later three companies are located on the East Coast. Additionally, Dr. Maida has been retained by Abraxis BioScience, Inc., Northwest BioTherapeutics, Inc. and Takeda Chemical Industries, Ltd. (Osaka, Japan). Dr. Maida holds a Ph.D. in Immunology, a B.A. degree in Biology, a B.A. Degree in History, a MBA and a MA in toxicology. He is a member of the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research

About Daily Stock Deals

Daily Stock Deals helps emerging growth companies reach individual and institutional investors. Daily Stock Deals and its affiliates publish research reports, market analysis and daily stock picks to help investors make informed decisions and achieve their individual investment goals. Our Platform is supported by companies we profile on our network, therefore, our views are neither free of conflict, nor intended as advise to buy/sell any securities and we strongly urge you to read our TOS, Disclaimer/Disclosure and consult with qualified experts. If you would like to get your company featured on Daily Stock Deals network or have any questions, please feel free to contact the editor. editor@DailyStockDeals.com thanks!

Daily Stock Deals is an affiliated/partner property, please read TOS/Disclaimer/Disclosure, thanks!

=====—–=====—-=-=-=-=-=-=-=-=-=-=====——-===-=-=-===-=-======——====-=-=

Genprex, GNPX, Profile, Summary

Genprex, GNPX, is a clinical stage gene therapy company pioneering a new approach to treating cancer. The company is developing gene technologies based on a novel proprietary technology platform, their first product candidate is called Oncoprex™ immunogene therapy, or Oncoprex, their platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles. The nanovesicles are then administered intravenously and are taken up by tumor cells where they express proteins that are missing or found in low quantities.

Oncoprex™, targets non-small cell lung cancer. This initial cancer target represents about 85 percent of all lung cancers and causes more deaths each year than any other type of cancer. Lung cancer is the second most common form of cancer, and the five-year survival rate for late stage lung cancer has not improved substantially in a quarter century. Oncroprex may be used alone or in combination with other cancer therapies, to combat additional types of cancer.

Fast Track

On January 14, 2020, the Company received U.S Food and Drug Administration (FDA) Fast Track Designation for its Oncoprex immunogene therapy in combination with the EGFR tyrosine kinase inhibitor (TKI) osimertinib (AstraZeneca’s Tagrisso®, which had worldwide sales in 2018 of $1.86 billion and $2.31 billion in the first nine months of 2019, and it is currently AstraZeneca’s highest grossing product) for the treatment of NSCLC patients with EFGR mutations that progressed after treatment with osimertinib alone. Oncoprex consists of the TUSC2 (Tumor Suppressor Candidate 2) gene, the active agent in Oncoprex, complexed with a lipid nanovesicle.

The Company’s current Phase I/II clinical trial utilizes the combination of the EGFR inhibitor erlotinib (marketed by Genentech in the U.S. and elsewhere by Roche as Tarceva®) and Oncoprex against NSCLC. The current Phase I/II trial is active but is not currently enrolling patients, though the Company had planned to resume enrollment in mid-2020. Tumor shrinkage in patients resistant to erlotinib enrolled in this trial showed that Oncoprex can overcome resistance to TKIs and provided support for the Fast Track Designation. Osimertinib is now considered a new standard of care for NSCLC patients with an EGFR mutation. Given this and receipt of FDA’s Fast Track Designation for use of Oncoprex combined with osimertinib in patients whose tumors progress on osimertinib, the Company has decided to prioritize this drug combination and patient population. Therefore, the Company plans to initiate a Phase I/II clinical trial of Oncoprex combined with osimertinib in mid-2020 at multiple cancer centers across the United States, and it does not intend to reopen enrollment in the current Phase I/II trial using the combination of Oncoprex and erlotinib at this time.

Genprex plans to file an amendment to its Investigational New Drug (IND) application with the FDA for the Oncoprex and osimertinib combination therapy trial within the first quarter of 2020. Upon FDA acceptance of the amendment, the Company expects to be in a position to enroll patients shortly thereafter. The Company believes that enrollment in the new clinical trial may be rapid, as the tumors of almost all patients who are treated with osimertinib progress after treatment, and these patients may be candidates for its clinical trial combining Oncoprex with osimertinib, for which the Company received Fast Track Designation.

The Company believes prioritizing the combination therapy of Oncoprex with osimertinib represents the most efficient way to advance its lead drug candidate through the clinical process for FDA approval, to have the best commercial success in the $17.9 billion global lung cancer market, the Company will also proceed with its plan to file an IND for the additional combination therapy of Oncoprex combined with the immunotherapy drug pembrolizumab (marketed as Keytruda® by Merck in the U.S.) for NSCLC.

Genprex and University of Pittsburgh Sign Exclusive License Agreement for Gene Therapy Candidate for Diabetes

Genprex recently signed an exclusive license agreement with the University of Pittsburgh for a diabetes gene therapy that may have the potential to cure Type 1 and Type 2 diabetes.The diabetes gene therapy, which was developed by lead researcher and Harvard graduate, Dr. George Gittes, at the Rangos Research Center at UPMC Children’s Hospital of Pittsburgh, works by reprogramming beta cells in the pancreas to restore their function, thereby replenishing levels of insulin. The novel infusion process uses an endoscope and an adeno-associated virus (AAV) vector to deliver Pdx1 and MafA genes to the pancreas. The proteins these genes express transform alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body’s immune system.

The diabetes gene therapy has been tested in vivo in mice and nonhuman primates. In studies of diabetic mice, the gene therapy approach restored normal blood glucose levels for an extended period of time, typically around four months. According to Dr. Gittes, the duration of restored blood glucose levels in mice could translate to decades in humans. Following preclinical studies, Dr. Gittes and his team plan to begin a Phase I clinical trial in diabetic patients, which could be the first-ever gene therapy tested in humans for diabetes.

Genprex’s licensed diabetes gene therapy technology works to reprogram alpha cells in the pancreas into beta-like cells, restoring their function, thereby replenishing levels of insulin.

Image source: Osipovich, Anna & Magnuson, Mark. (2018). Alpha to Beta Cell Reprogramming: Stepping toward a New Treatment for Diabetes. Cell Stem Cell. 22. 12-13. 10.1016/j.stem.2017.12.012.

According to the American Diabetes Association, more than 30 million Americans have diabetes, and approximately 1.5 million Americans are diagnosed with diabetes every year. Diabetes patients have the continuous burden of checking and monitoring their blood glucose levels and injecting insulin on a daily basis. Without effective management of diabetes, patients are at risk of stroke, hyperglycemia, cardiovascular disease, diabetic ketoacidosis and extremity amputation. Diabetes is the seventh leading cause of death in the U.S.

Source: Genprex, OxBridge Research, Daily Stock Deals

About Daily Stock Deals

If you would like to get your company featured on OxBridge Research or like to learn more, please contact the editor. Thank you!

=-=-=-=-=-=-=-===–===-=-=-=-=–=-=-=-=–=-=-=-=-=-=-=-=-=-=-=-=-==-=-=-=-=-=-=-==

iQSTEL, IQST, Company Profile, Summary

iQSTEL, IQST, is based in Florida and serves mainly countries in the Caribbean and Latin America, the region of Latin America and the Caribbean is one of the fastest growing consumer markets in the world.

The company’s top executives have a great insight and deep knowledge of the region, its people and know how the governments in these countries operate. The unique insight has helped the company establish successful telecom, transport and financial services in each country then they manage to interconnect consumers from their neighboring countries, opening up more opportunities for people to communicate and trade and loop back to the USA, making the network as a whole more valuable and scalable. iQSTEL has created a vibrant ecosystem that has been growing each year, contributing double digit revenue gains and helping company introduce new services and gain more customers.

Telecom

Services: SMS, VoIP, PBX, Omnichanel services, International Fiber-Optic connectivity for 5G.

Electric Vehicle (EV)

Services: Electric Motorcycles for Latin America, One – Stop – Shop solutions for Electric Vehicles (EV) industry: EV Batteries, EV Chargers, EV Battery Management System, IoT Connectivity, Mobile App for EV connectivity, EV Dashboard Display, etc.

Fintech

Services: Visa/Mastercard Money One (Visa/Mastercard debit card), Remittances, Mobile Top Up, Cryptocurrencies Exchange Services.

Technology (IoT)

Services: Internet of Things (IoT) Devices and Platforms IoTSmartGas, IoTSmartTank.

Blockchain

Services: Blockchain Platforms Solutions: Mobile Number Portability Application (MNPA), Settlement and Payment Marketplace (SPM).

About Daily Stock Deals

Daily Stock Deals is an affiliated/partner property, please read TOS/Disclaimer/Disclosure, thanks!

-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-

Top 10 Most Visited US Websites, Top 10 US Portals

=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-==-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=

DigitalTown, DGTW, Company Profile, Business Summary

DigitalTown, DGTW, Corporate Profile

DigitalTown (DGTW), a fully reporting publicly traded company currently listed on the OTC Markets, however, the company has plans in place to up-list on NASDAQ/NYSE in the near future.

DigtalTown is a unique company partnering with city governments to build strong, resilient communities and flourishing local businesses.

DigitalTown provides cities a highly scalable, digital infrastructure that helps cities connect with citizens and local businesses with ease. The DigitalTown powered, mobile friendly, city portal empowers citizens to interact directly with city leaders, local government agencies and businesses.

Act Local Think Global

DigitalTown changing the landscape one city at a time, helping build smart cities and better governments. City governments eagerly embracing DigitalTown’s vision because it helps cities provide better services quickly and cost effectively. DigitalTown’s has a unique ability to capture big-data at a very granular level, the unprecedented access to information helping city mayors and administrators plan better cities, better communities and optimize the use of city resources.

Changing Dynamics of Local Commerce

Partnering with DigitalTown helps cities collect taxes and fees efficiently and cost effectively, and helps local businesses sell more products and services to people in their own communities. Research shows that people want to patronize local businesses, unfortunately, they don’t have easy access to buy local. DigitalTown changing the dynamics of local commerce, empowering cities and citizens like never before.

Helping Cities and Citizens

DigitalTown powered city portal helps citizens and businesses pay their utility bills, property and business taxes and buy and sell goods and services without leaving the city portal. The portal acts like town square, bustling with commerce, increasing social interaction and community engagement. The company believes that this will help increase standard of living, reduce crime, increase property value and attract more people and businesses to DigitalTown powered cities.

Highly Scalable, Cloud Based Platform

DigitalTown’s highly scalable, cloud based platform built for highly interconnected, extremely dynamic and mobile friendly cities of the future. Digital Town bringing people together and changing the landscape of cities and towns.

Why Invest in DigitalTown?

DigitalTown is a unique, high growth, extremely scalable SaaS platform, and it has many streams of income. The company generates revenues through licensing fees, software development and integrations fees, payment processing fees, native ads and sponsored content and other sources.

DigitalTown powered city portals are social and commerce hubs, consumers recommend their favorite restaurants & beauty shops, write reviews, discover local events, find doctors, dentists and plumbers. The portal helps peer-to-peer and consumers-to-business communication, helping consumers connect with each other and shop local.

DigitalTown provides a one stop shopping for all the goods and services from a single platform. DigitalTown helps cities and business process transactions and facilitates safe and secure payments. Local businesses could easily integrate and/or build their own digital stores. Research shows that most consumers for personal data security reasons are reluctant to shop on obscure, small store websites, DigitalTown helps alleviate the concerns and encourages people to shop at their favorite local stores. Every transaction on DigitalTown is end-to-end encrypted, therefore, your personal and payment information stays secure and out of the reach of data thieves.

DigitalTown Growing Rapidly

The company is growing organically and through smart acquisitions. The company acquired and successfully integrated half a dozen companies and looking to acquire more as it continues to grow at a rapid pace.

Recently acquired companies

The Management Team

The DigitalTown team is led by successful technology managers who have a passion for economic development and fostering robust local economies.

Robert W. Monster

CEO & President

Robert joined DigitalTown at CEO in 2015, bringing significant experience with him. Among his many accomplishments, he founded and served as Managing Director of Monster Venture Partners LLC, and founded Global Market Institute (GMI). Prior to founding GMI, he was a global product development manager at Procter & Gamble. Robert earned both a BS and an MBA from Cornell University. He was recognized as Ernst & Young’s 2006 Entrepreneur of the Year. He also authored Market Research in the Internet Age, published by John Wiley and Sons.

Chris Maxwell

Chief Technical Officer

Chris leads DigitalTown’s development team. He’s responsible for engaging with clients to understand their challenges and needs, and delivering customized solutions to meet them. Prior to joining DigitalTown, he founded Cloud.Market, an online marketplace serving local communities. He was a senior technical program manager at Amazon, CTO of Voxeo Labs (acquired by Aspect), and held leadership and technical roles at Tellme (acquired by Microsoft), AT&T, Edify, Intervoice (acquired by Convergys), Verizon and EDS. Chris earned a BA from Baylor University and an MBA from the University of Dallas.

Adee Wada

Vice President, Marketing

Adee leads DigitalTown’s marketing efforts. He comes from Microsoft, where he spent eight years serving in their Online Media Business division, most recently as Director of Audience Marketing. Prior to Microsoft, he was the Director of Event Services for the Seattle Mariners, overseeing operations at Safeco Field. He earned a BA from the University of Colorado. Adee enjoys life in Bellevue with his wife and three children.

Ken Cooper

Vice President, Finance

Ken brings years of financial experience to DigitalTown, founding and directing Four Hills Advisors. Prior to Four Hills, he spent 14 years at Life Time Fitness, Inc., serving in many roles, helping them grow from $53 million in revenues to over $1 billion. He led their investor-relations efforts from Life Time’s IPO in 2004 thru 2010. He helped garner over $1 billion in capital for the company, and built their blueprint for strategic decisions for years to come. He also led their Athletic Events & Endurance division, as well as serving in their M&A department.

Ken Jensen

Vice President, Engineering

For 20 years, Ken led Software Masters. Acquired by DigitalTown, the company developed website solutions for communities and local governments. Since coming on board, he has taken primary responsibility for the development of software solutions for local governments.

Faris Oweis

Vice President, Corporate Development

Faris has experience in countless industry verticals from tech to architecture. He’s a storyteller, listener, strategist, rapid learner, and a natural connector of ideas who has secured projects across 8 industries in over 30 countries. Prior to DigitalTown, Faris led large pursuits for CH2M with a focus on mega infrastructure and smart city projects across the Middle East and India. School wise he holds a B.S. in Marketing from Virginia Tech (Go Hokies) and MBA from Auburn (War Eagle).

Clint Skidmore

Vice President, Product Development

Since 2001, Clint has been fuelled by a passion for combining technology and travel into a market-leading software solution for the travel industry. As CEO of Rezserve Technologies Ltd, Clint has brought his vision to life, enriching yet simplifying the user experience of booking lodging and other travel related products. Since coming on board at DigitalTown through the acquisition of Rezserve, Clint has led product development and use his experience and expertise to increase the usability and functionality of DigitalTown with an emphasis on providing intuitive Merchant Solutions that help businesses of all sizes to win locally and compete globally.

Ala Dadan

Vice President, Product Design

With over 14 years of experience in new media design. Ala Dadan leads the design efforts behind the new product features in DigitalTown.com across their full life cycle — concept, scope, design comps, and prototype support. He started his career in 2001 & during that time he was a member of different design teams in several companies in Jordan – the Middle East and as a consultant for many design firms abroad. Mr. Dadan has also served as Vice President of Design at Epik.com and was the founder of O2 Alternative, a trend-setting design house in Jordan.

Kenneth A. Holloway

Marketing Director

Kenny joined us in March 2016. As Marketing Director, Kenny oversees the knowledge base, training, support and SEO. Prior to DigitalTown, Kenny had spent over a decade at the helm of 360 Media Group. Kenny brings a wide range of experience with media buys, traffic generation, web development and is a published photographer.

Please visit the company website DigitilTown.com and learn how DigitalTown helping local communities. Make your city a – DigitalTown Empowered City – today!

Don’t miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® Disclaimer/Disclosure: we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks. If you want to learn more or get your company featured on Daily Stock Deal, please contact the Editor. editor [@] DailyStockDeals.com

Omagine, OMAG, Company Profile

Posted on July 4, 2016 by Daily Deals

Omagine, Inc. (OTCQB: OMAG) Profile, Summary

Omagine is an entertainment, hospitality and tourism company with significant residential and commercial real estate development and property management activities.

The company is headquartered in New York City and has a subsidiary in Muscat, Oman. Omagine is focused on MENA Region real-estate development and hospitality opportunities because the company believes the enormous financial resources in the MENA region combined with a recent shift in economic development strategies of regional Governments present huge opportunities. (See how OMAG could benefit from it, click here)

The Vision

The company has signed a $2.5 billion development agreement with the Government of Oman, developing a mixed-use Tourism/Residential and Commercial/Retail project known as – The Omagine Project. The 245 acre prime beachfront property is located just 6 miles from Muscat International Airport. The beautiful Pearl shaped buildings will overlook the serene Gulf of Oman, surrounded by a vibrant art and culture scene, poised to inspire the world.

The Omagine Project is designed as an exquisite, modern architectural marvel built with environmentally friendly materials in a family friendly living/working space. It blends local values and customs for today’s global citizens where residents and visitors live, work and play in complete harmony with nature.

The existing majestic Sultan Qaboos Street, home to Muscat’s many landmarks, provides easy access to The Omagine Project, where art and culture thrive, residents and visitors experience Arabian hospitality, dine in fine restaurants and shop at exclusive showrooms of global brands. (See project overview, click here)

The Future

Most Americans are familiar with The Palm Islands of Dubai. The Palm started with a vision and a simple rendering, despite huge challenges, the vision came true. Dubai became one of the world’s top tourist destinations and one of most expensive real estate markets in the world.

THE PALM

The Omagine Project – and its Pearls – has the potential to become the next major tourism destination and one of the most highly desired real estate markets. Muscat could become the next hot destination for the tourists around the world.

The Omagine Project – The Pearls

Timing and Location is Everything!

The timing couldn’t be better for Chinese investors. The Stock Market in China down sharply and the Chinese economy slowing down considerably. Chinese investors looking for an alternative, discovered Dubai. Investors from China are flocking to Dubai. Huge demand from investors is driving up real estate prices in Dubai and the cost of living and doing business in Dubai has increased dramatically.

We believe, The Omagine Project (Muscat) offers the next great opportunity for investors and Global corporations doing business in the Middle East. Muscat’s low cost of living and cheaper office space offers a better ROI.

The Pearls (Muscat) expected to meet or exceed the lifestyle choice and luxury for less. It’s a great opportunity for Global corporations to establish their MENA headquarters in Muscat. Also, a unique opportunity for accredited investors seeking to diversify their portfolios.

Source: The Company, OxBridge Research, Daily Stock Deal, OTC King, OTC Stock Wire

Don’t miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® Disclaimer/Disclosure: we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks. If you want to learn more or get your company featured on Daily Stock Deal, please contact the Editor. editor [@] DailyStockDeals.com

================================================================

$2.5 billion Omagine pearl project set for 2017 in Oman

July 12, 2016

by Rahul Das/rahuldas@timesofoman.com

Muscat: Construction work on the multi-billion dollar Omagine Project is scheduled to begin in 2017 and should be complete by 2024, according to the Ministry of Tourism (MoT).

Located in Seeb, the project features seven pearl-shaped buildings which will host hotels, offices, residences and entertainment venues on one million square metres of land, the MoT said.

The project is expected to create more than 1,000 jobs for nationals when it is completed in seven year’s time. The slump in global oil prices has meant project managers have been seeking further funding globally, according to Omagine chairman Frank J. Drohan.

Speaking to Times of Oman, Drohan said that they are in advanced discussions with several institutional and private entities in the United States, Europe and China to finance the project as a quite rational response to the present regional banking environment. “Other companies and governments regionally are quite rationally also reaching out to the international financial markets,” he said.

Drohan said that the longer term project finance is needed only after the detailed master planning and architectural design is completed. “And that is the reason we are working hard on many fronts with Consolidated Contractors Co (CCC) and other investors in Oman and the GCC, Europe, the US and China to make that happen,” he said.

It was in October 2014, Omagine LLC, signed a development agreement with the Government of Oman for the development of a $2.5 billion real-estate and tourism project known as the Omagine Project.

In March 2015 the Ministry of Finance in Oman ratified the development agreement. In July 2015 the development rights to the 245 acres of beachfront land were registered with the government of Oman. In May, Omagine Inc. also sponsored The World Summit on Innovation & Entrepreneurship (WSIE) at the United Nations Headquarters in New York City.

The Omagine Project will have three hotels (which will include serviced apartments and chalets), a boutique mall, an open air amphitheatre, exhibition venues, a harbour and marina area, offices, more than 2,000 residences and a large number of cafes, restaurants and entertainment venues. The Omagine Project will have seven pearl shaped buildings, each with a different theme, such as the Oman Pearl, Innovation Pearl, Energy Pearl, Culture Pearl and Earth, Sea and Sky Pearls.

The Pearls will feature a wide range of tourism experiences, simulations, games, interactive demonstrations, multi-media presentations and a planetarium and a multiplex.

To learn more, please visit the company website: Omagine.com

Source: Times of Oman

================================================================

OTCKING.COM Features DSGT, a Leading GPS and Ad Platform

Posted on June 28, 2016 by Daily Deals

How GPS Technology and Data Are Helping the Golf Business Monetize More Effectively

SURREY, BC / ACCESSWIRE / June 28, 2016 / DSG GLOBAL INC. (DSGT) is a proven industry leader, whose TAG Systems solution is used by over 300 major golf courses around the world to track their fleets of golf carts and turf equipment. DSG with its sophisticated data capturing technology is quickly becoming a leader of data capture in the golf industry.

“There’s Google, Apple and now DSG,” said Adrian Fulle, Chief Marketing Technologist at DSG. “Our digital assets are already deployed on hundreds of golf courses around the world and we are in a unique position to capture data on fleets of golf carts and golf courses.”

(To learn more about DSG TAG Systems click here) (For Company Profile click here)

The company’s executive team has over 50 years of combined experience in GPS technology and the company spent millions of dollars developing their solutions. The simple, but effective TAG System is a solution for fleet managers and operators by providing smart routing, 24/7 monitoring and real-time alerts to increase productivity and safety.

Through their interactive TOUCH solution on golf carts and other fleet vehicles, DSG is able to gather intelligent data about key consumer habits.

“Golf is one of the best consumer segments for data gathering,” explained Fulle. “Golfers are among the most affluent and have high disposable income. And when they’re playing a round of golf, they’re a captivated audience for 4 hours or more and they’re most likely to interact with our digital assets. It doesn’t get much better than that for advertisers.”

The data collected through this technology has become a valuable asset for the company and its clients. The company’s R3 advertising revenue program, due to launch in July, will utilize this data to the advantage of courses and advertisers.

“Knowing your fleet history and how your fleet operates from the micro to the macro is extremely important for making informed decisions on future operations, but knowing your consumer, the golfer, is just as valuable. It allows the golf course operators to create better and better experiences for the golfing consumer and for advertisers to display more and more relevant advertising. It’s win-win for everyone,” added Fulle.

Visit DSG Global at dsgtag.com or FACEBOOK or TWITTER.

Safe Harbor for Forward-Looking Statements

This information contains forward-looking statements. Forward looking statements in this press release include statements relating to the Company’s corporate finance and other strategic initiatives, and the Company’s expansion into markets outside of the golf industry. Forward-looking statements are inherently subject to risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, including, without limitation, the following: the timing and nature of any capital raising transactions; our ability to offer products and services for use by customers in new markets outside of the golf industry; the risk of competition; our ability to find, recruit and retain personnel with knowledge and experience in selling products and services in these new markets; our ability to manage growth; and general market, economic and business conditions. Additional factors that could cause actual results to differ materially from those anticipated by our forward-looking statements are under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” filed with the Securities and Exchange Commission. The Company disclaims any obligation or undertaking to update forward-looking statements.

For information please contact Investor Relations:

DSG Global Inc.
(877) 589-8806

SOURCE: DSG Global Inc.

Daily Stock Deals Initiates Profile Coverage on DSG Global (OTCQB: DSGT)

Posted on June 8, 2016 by Daily Deals

How a Small Big Data Company Could Help Save Thousands of Lives on American Highways and Save Millions of Dollars for the Trucking Industry

SURREY, BC / ACCESSWIRE / June 7, 2016 / DSG GLOBAL INC. (DSGT), a proven industry leader, whose TAG Systems solution used by over 300 major golf courses around the world to track their fleets of golf carts and turf equipment, is gearing up to track trucking in real time, improve highway safety and increase ROI for truck owners.

“After perfecting our game on the greens, we’re ready to literally take our solutions on the road,” said Robert “Bob” Silzer, Sr., CEO and President at DSG. “Trucking is the next logical step for us and to be able to assist that industry with their operations in multiple ways is a great thing.”

(To learn more about DSG TAG Systems click here)

Daily Stock Deals has stated in its coverage (See full profile click here) that over 15,000,000 (fifteen million) trucks traverse American highways transporting trillions of dollars of goods from coast to coast every year. Highway fatalities in recent years increased sharply and property damage claims have skyrocketed to billions of dollars.

“Trucking is the lifeblood of our country,” said Adrian Fulle, Chief Marketing Technologist at DSG. “It accounts for a whopping 70% of all shipping in North America. To be able to track in real time, know where any shipment is at any given moment and send help if there’s an issue is priceless to our nation’s economy.”

DSG Global’s proprietary TAG technology combines the advanced GPS TAG and the TAG Management Center software to help save lives, reduce fuel costs, improve on-time delivery and save millions of dollars in property damages.

The data collected through this technology has become a valuable commodity for the company and its clients.

“Knowing your fleet history and how your fleet operates from the micro to the macro is extremely important for making informed decisions on future operations,” added Silzer.

Visit DSG Global at dsgtag.com or FACEBOOK or TWITTER.

Forward-looking statements: The Company’s actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements, including those described in the Company’s Financial Statements, Management Discussion and Analysis and Material Change Reports filed with the Canadian Securities Administrators and available at www.sedar.com, and the Company’s 20-F annual report filed with the United States Securities and Exchange Commission at www.sec.gov. This profile/research report/email letter/blog/posting in forums/social-media/t/f does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities of the Company have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Disclosure/Disclaimer: Daily Stock Deals (DSD) publishes sponsored research reports, advertorials and corporate profiles on its portal and several other websites/blogs, including this website/blog, owned and operated by DSD and/or its affiliates. DSD is not a Broker Dealer or a Registered Financial Adviser in any jurisdiction, whatsoever. All the information published on its website(s) and/or distributed to its members via various electronic means is for general awareness and entertainment purpose only. DSD urges investors to do their own due diligence and consult with their financial adviser prior to making any investment decision. We are expecting a payment of up to five thousand dollars in compensation from the company/a third party/shareholder. We receive compensation from companies for providing various IR services, including publication, advertisement, and social media awareness, therefore our views/opinion are inherently biased. Please read the full disclosure/disclaimer, if you need assistance contact Editor@DailyStockDeals.com. All Rights Reserved. Trademarks/logos are of their respective owners.

SOURCE: Daily Stock Deals

DSGT, DSG Global, Company Profile

Posted on June 1, 2016 by Daily Deals

DSG Global, DSGT, Profile, Summary

DSG Global, Inc. (DSGT), a global leader in fleet management, providing comprehensive solutions for the Golf Industry, Commercial Fleets and critical applications for Military and other Government agencies.

The Company’s CEO has over 20 years of industry experience and, the executive team has over 50 years of combined experience, in designing and deploying Wireless networks and GPS tracking systems around the globe. (executive bios: management team, board of directors)

Proven Golf Course Management

DSG is unique in the industry, like Apple®, DSG is a hardware and a software company. Today over 15,000 vehicles on more than 300 Golf courses, around the world, run on DSG TAG system. (Testimonial From Happy Clients click here )

The United States alone has more than 15,000 Golf courses, the company has the potentially to capture thousands of Golf courses in the near future.

Comprehensive Commercial Fleet Management

From the Port of Long Beach, California to Portland, Maine, 15,000,000 (fifteen million) Trucks traverse America’s Highways, transporting goods worth trillions of dollars every day. Trucking industry in America is very diverse, thousands of owner/operators and companies with a fleet of thousands of trucks power American businesses. Most of these trucks are not equipped with advanced monitoring and routing systems.

DSG TAG System (DSGT) has the solution that could potentially save trucking industry billions of dollars, help increase safety and save precious lives on American Highways. DSGT has spent millions of dollars developing technology to improve safety and increase productivity. DSGT provides vertically integrated solution to help fleet owners better manage their assets and increase revenue. The software helps find safer and better routs, help increase on-time deliveries, keep customers happy and save fleet owners millions in maintenance and fuel cost. Savings & Benefits

Trucks Carry Goods worth Trillions of Dollars

Trucking industry is huge, there is no dominant player in GPS market, and the largest incumbent has under 40 thousand trucks under management. DSGT has technological and cost advantage over the competition that could help the company rapidly gain market share. DSGT is gearing up, adding more marketing staff to take advantage of multi-million dollar, recurring revenue, opportunity.

Partnered with Industry Leaders

Source: The Company, OxBridge Research, Daily Stock Deal, OTC King, OTC Stock Wire

Don’t miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

Disclaimer/Disclosure: we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks. If you would like your company featured or want to learn more, please don’t hesitate to contact the Editor. editor [@] DailyStockDeals.com

Twitter looking great, catch the bird, hit 52wk Lows, hot picks: SQNM, TWTR,HEB,VRNG

Posted on January 20, 2016 by Daily Deals

Daily Stock Deals Retweeted

‏@Dailystockdeals

@TOP10STOCKS Hot Stocks $SQNM $TWTR $HEB $VRNG @twitter huge rebound! more picks at http://www.DailyStockDeals.com

Gas prices plunged, hit the lowest level, under a dollar per gallon, fracking pains hit Texas, North Dakota, Oklahoma hard

Posted on January 18, 2016 by Daily Deals

Gas prices plunged, Michigan became the first state, gas prices hit $0.79/gallon, may miss inflation target, do you think Yellen should raise rates?

Your opinion counts, let us know: Daily Stock Deals

Frackers freaking out

XLI Technologies, XLIT, Profile, Summary

Posted on December 8, 2015 by Daily Deals

XLI Technologies, XLIT, Profile, Summary

XLI Technologies, Inc. is a technology and multimedia distribution company, featuring just one of their products and services: Printed LightSheets. XLI Technologies, Inc., provides innovative lighting solutions within the multimedia, theatrical distribution, and entertainment sectors. Our unique Printed LightSheets technology enables us to provide an exceptional value proposition for our clients as well as their customers, by delivering cutting-edge positioning techniques as well as movie production tools. In addition to leading the way in technology, our business model enables our clients to maximize their profitability in the interest of fostering mutually beneficial financial opportunities.
NANOTECHNOLOGY

Nanotechnology is the manipulation of matter on an atomic, molecular, and supra molecular scale. XLI Technology brings Printed LightSheets’ Nanotechnology to market: a revolutionary, patented light source that gives off vibrant colors and provides a highly efficient, 100% environmentally friendly light-source alternative.
AUTOMOTIVE INDUSTRY

XLI Technologies puts advertising and promotion on the move with its Printed LightSheets offerings for the automotive industry. Options run the gamut in exterior lighting surfaces, with car hood wraps, quarter-panel lighting and windows that make an indelible impression. In the interior, eye-catching capabilities include illuminated headliners, seats, floormats, displays and interior door panels.
LIGHT UP MOVIE THEATER ADS AND PROMOTIONS

When it comes to advertising and promotions, drawing attention and increasing focus are absolutely paramount. In addition to improving the visual impact of traditional poster presentations in the theater environment, Printed LightSheets offers new and creative advertising space in areas where advertising was unable to effectively be used before, such as “canvertizing” (advertising on a trashcan). Each additional square foot of light advertising creates an environment of excitement and additional advertising revenue opportunities.
PRODUCTION LIGHTING

XLI Technologies’ motion picture division is focused exclusively on products for movie studios, production and distribution companies, advertising, and talent and management agencies. This program offers volume discounts with fast delivery (same day, overnight, 5-day and/or 10-day delivery). Every Printed LightSheet comes with a transformer that powers the Printed LightSheet. Portable Backlit Packages are available for all 5 sizes—so light, portable and convenient that they can be considered a carry on when flying and traveling. (All Printed LightSheets also come with a warranty.) The current standard configurations include:
Sources: The Company, OxBridge Research, OTCKING, DailyStockDeals, OTCstockIQ

Don’t miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
Disclaimer/Disclosure: we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.
If you would like your company featured on our network, please don’t hesitate to contact the Editor. editor [@] DailyStockDeals.com

Tanaris Power, TPHX, Profile

Posted on June 10, 2015 by Daily Deals

Tanaris Power, TPHX, Profile, Summary

Tanaris Power develops Smart Lithium-Ion batteries and power solutions for various industrial applications. We design, engineer and produce some of the worlds safest, highest performance, most reliable and flexible Lithium-Ion batteries.

Tanaris Power lithium-ion batteries feature best-In-class safety, reliability, performance and flexibility for your industrial power applications
All Tanaris Power battery packs are based on Lithium-ion battery technology. Each of our batteries incorporates our advanced Battery Management System (BMS) along with numerous redundant safety and performance features to ensure that our batteries are the safest, most reliable, best performing and flexible batteries available

Tanaris Power Lithium-Ion Benefits
Our lithium-ion batteries offer numerous benefits over conventional lead-acid batteries, including:
Significantly improved vehicle performance
Significantly longer run time between charges
Short duration charging has no negative effects
3x to 5x longer life span than lead-acid batteries
65-70% less weight than similar lead-acid packs
Completely maintenance free operation
No acid vapor, maintenance or storage risks
Integrated BMS for system monitoring and safety
Ruggedized design for extreme outdoor use
Safety
Your safety is at the core of every design decision and component selection we make
All of the Lithium-Ion cells we use must meet international UN38.3 standards for safe transportation and usage
We use the Lithium-Iron-Phosphate chemistry for our cells, which provides a level of thermal stability that some other cell chemistries do not offer
Every battery we make incorporates a dedicated advanced Battery Management System (BMS) along with other redundant intelligent monitoring circuitry that monitors each individual cells’ operation and temperature to ensure that the whole pack operates safely
Each and every battery incorporates numerous additional safety features such as an integrated battery isolation fault monitoring system, redundant fuses, sealed safety relays, audible alarms and much more

Reliability
We only use the best quality automotive grade components to ensure maximum reliability
Each and every one of our batteries and the components that go into them, go through extensive burn-in and testing processes before they make it into any Tanaris Power battery
Every batch of Lithium-Ion cells are subjected to an array of standardized tests to ensure they are well qualified before they go into any battery
All cells are are secured using specialized hold-down mechanisms within the battery to reduce shock and vibration

BMS and all electronics are designed to strict automotive standards, using only automotive and industrial grade components, for the highest level of reliability in all operating environments
All battery cases and electronic connectors are sealed to ensure the battery will work in all weather conditions

Performance
Rigorous in-house cell testing and characterization allows us to manage and optimize the cell selection for each battery application, ensuring optimal power delivery for the life of the system
We test and evaluate cells from a wide variety of manufacturers to find the best performing cells
Our advanced Battery Management System maintains peak performance of all cells in real time
Proprietary cell balancing algorithms ensure that all battery cells maintain their balance at all times
All aspects of battery charging are under real time monitoring and direct control of the BMS which means the BMS selects the appropriate charging profile in order to extend battery life
Cell behavior is learned with usage, which allows the system to better predict vehicle demands and understand overall battery health flexibility
The BMS calculates and compares cell-by-cell performance to ensure peak battery performance

Flexibility
Battery packs are available in industry standard voltage levels such as 24V, 36V, 48V, 72V and 80V
Battery capacity can be selected to match application requirements at each voltage level, from 40Ah to 900Ah
Single or multi-module battery pack configurations are available depending on specific space or layout requirements
Physical dimensions of many battery modules can be customized to client specific needs
Integrated CAN bus communications can be customized to interface with other intelligent equipment such as on-board chargers, charging stations, motor controllers, driver displays, etc.
BMS control logic can be customized to interact with and control other vehicle equipment such as emergency stop button, key-switches, analog or digital gauges, mode selection switches, buzzers, sirens, lights and more

Sources: The Company OxBridge Research, OTCKING, DailyStockDeals, OTCstockIQ
Don’t miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
Disclaimer/Disclosure: we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.
If you would like your company featured or want to learn more, please don’t hesitate to contact the Editor. editor [@] DailyStockDeals.com

Viking,VKIN,Profile,Summary

Posted on June 8, 2015 by Daily Deals

Viking Investments Group, VKIN, Profile, Summary

Viking Investments Group provides professional advisory and consulting services to companies undergoing or anticipating periods of rapid growth, significant change or ownership transition, and when justified, staffing, financing, and/or providing operational support to such companies. Target companies must have superior management, intimate knowledge of their particular industry and a sound business plan, along with a desire and receptiveness for specific expertise to advance the company’s business objectives.

Viking’s primary focus is directed toward North America, targeting various industries,mainly in the Oil & Gas sector and other selective sectors, with appropriate diversification and balance between each. Viking targets under-valued businesses with realistic appreciation potential and a defined exit strategy.

Current Projects

The Joffre D-3 Oil Project is located in the Leduc D-3 B Pinnacle Reef in Central Alberta, Canada (the “Joffre Project”).

Viking owns a 50% working interest in the Joffre Project which consists of 4 oil wells and one water injection well. The wells were previously suspended. Viking and Tanager Energy Inc., Viking’s partner for this project, mobilized the first well (production commenced on April 1st, 2015), and intend to mobilize the remaining wells sequentially.

After 5 days of anticipated monitoring and operating facility adjustments, the well is now producing at a rate of 118 barrels of oil per day of 38 API gravity crude oil and 250 mcf of natural gas, totaling 160 BOE/D. The well is a flowing oil well with a flowing wellhead pressure of 435 psi.

Viking estimates to complete the re-work of the remaining wells during the second and third quarter of 2015.

Mobilization and reactivation efforts involve, among other things, completing the re-entry and downhole pressure survey to determine the current reservoir pressure, a critical element in determining the scope and anticipated production of this suspended oil pool. The survey with respect to the first well confirmed the reservoir pressure returned to 94% of the original pressure (i.e. the pressure that existed when the pool was discovered in 1986) due to the active water drive in the pool.

Following the pressure test described above, a production test is performed to confirm the productivity of the pool. The production test for the first well occurred between January 13th and January 15th, 2015 and the test results indicated the following:

a stabilized production rate of 290 BOE/d (235 barrels per day of oil and 325 mcf/d of gas).
the flowing wellhead pressure was stable at 475 psi, estimated to be a 7.7% drawdown of the reservoir. On a metric equivalent basis this is 52.5 cubic meters oil equivalent per day at 3265 kpa flowing wellhead pressure.
The fluid produced was 100 percent high gravity oil.

Sources: The Company, OxBridge Research, OTCKING, DailyStockDeals, OTCstockIQ
Don’t miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
Disclaimer/Disclosure: we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.
If you would like your company featured or want to learn more, please don’t hesitate to contact the Editor. editor [@] DailyStockDeals.com

Dr. Vuong was a joint patent holder who helped develop the block-buster billion dollar drug Abraxane™ – now owned by Bristol-Myers Squibb, NYSE: BMY, a $144 billion dollar company.

Keytruda meet > OT-101

iQSTEL, IQST, Company Profile, Summary

Top 10 Most Visited US Websites, Top 10 US Portals

DigitalTown, DGTW, Company Profile, Business Summary

Dr. Vuong was a joint patent holder who helped develop the block-buster billion dollar drug Abraxane^™– now owned by Bristol-Myers Squibb, NYSE: BMY, a $144 billion dollar company.